Immunovant Executives Sell Shares to Cover Tax Obligations
閱讀少於1分鐘
| Reporter Name | Relationship | Type | Amount | SEC Filing |
|---|---|---|---|---|
| Stout Jay S | Chief Technology Officer | Sell | $26,187 | Form 4 |
| Geffner Michael | Chief Medical Officer | Sell | $19,998 | Form 4 |
Immunovant's Chief Technology Officer, Stout Jay S, and Chief Medical Officer, Michael Geffner, have both sold shares of the company's common stock to cover tax withholding obligations related to the vesting of restricted stock units.
Stout Jay S sold 1,519 shares on July 9, 2025, at a weighted average price of $17.24 per share, totaling $26,187. Following this transaction, Stout directly owns 207,724 shares of Immunovant's Common Stock.
Michael Geffner sold 1,160 shares on the same day, at the same price of $17.24 per share, totaling $19,998. After this sale, Geffner directly owns 224,210 shares of the company.